The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
The mutation rate and cancer
Open accessAbstract
The selection of advantageous mutations underlies tumorigenesis. The growth of a tumor is therefore a form of evolution at the somatic level, in which the population is comprised of individual cells within the tumor. Models of tumorigenesis have considered the relative importance of mutation and selection. We show that selection is more important than an increased mutation rate in the growth of a tumor. Some cancers may acquire a “mutator phenotype,” probably leading to faster growth, but mutator phenotypes are not necessary for carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,582
The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis
Armitage, P., & Doll, R. (1954) · British Journal of Cancer · doi:10.1038/bjc.1954.1 · Cited by 1,549
(1991) · PubMed · Cited by 1,305
The age distribution of cancer and a multi-stage theory of carcinogenesis
Armitage, P., & Doll, R. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602297 · Cited by 1,285
Mutation and Cancer: A Model for Human Carcinogenesis2
Moolgavkar, S. H., & Knudson, A. G. (1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1037 · Cited by 1,086
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability
Liu, B., Nicolaides, N. C., Markowitz, S., Willson, J. K. V., Parsons, R. E., Jen, J., Papadopolous, N., Peltomäki, P., de la Chapelle, A., Hamilton, S. R., et al. (1995) · Nature Genetics · doi:10.1038/ng0195-48 · Cited by 802
A Two-stage Theory of Carcinogenesis in Relation to the Age Distribution of Human Cancer
Armitage, P., & Doll, R. (1957) · British Journal of Cancer · doi:10.1038/bjc.1957.22 · Cited by 555
Hereditary cancer: Two hits revisited
Knudson, A. G. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01366952 · Cited by 491
Cited by
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
The causes and consequences of genetic heterogeneity in cancer evolution
Burrell, R. A., McGranahan, N., Bartek, J., & Swanton, C. (2013) · Nature · doi:10.1038/nature12625 · Cited by 2,262
The origin and evolution of mutations in acute myeloid leukemia
Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.023 · Cited by 1,575
Somatic mutation in cancer and normal cells
Martincorena, I., & Campbell, P. J. (2015) · Science · doi:10.1126/science.aab4082 · Cited by 1,396
The Acidic Tumor Microenvironment as a Driver of Cancer
Boedtkjer, E., & Pedersen, S. F. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034627 · Cited by 1,223
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Marusyk, A., Janiszewska, M., & Polyak, K. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.007 · Cited by 1,009
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
Role of mutator alleles in adaptive evolution
Taddei, F., Radman, M., Maynard-Smith, J., Toupance, B., Gouyon, P. H., & Godelle, B. (1997) · Nature · doi:10.1038/42696 · Cited by 677
Intra-tumour diversification in colorectal cancer at the single-cell level
Roerink, S. F., Sasaki, N., Lee-Six, H., Young, M. D., Alexandrov, L. B., Behjati, S., Mitchell, T. J., Grossmann, S., Lightfoot, H., Egan, D. A., et al. (2018) · Nature · doi:10.1038/s41586-018-0024-3 · Cited by 551
The role of chromosomal instability in tumor initiation
Nowak, M. A., Komarova, N. L., Sengupta, A., Jallepalli, P. V., Shih, I.-M., Vogelstein, B., & Lengauer, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202617399 · Cited by 523
DNA Damage, Mutagenesis and Cancer
Basu, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040970 · Cited by 522
Rowan, A. J., Lamlum, H., Ilyas, M., Wheeler, J., Straub, J., Papadopoulou, A., Bicknell, D., Bodmer, W. F., & Tomlinson, I. P. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3352 · Cited by 500
Self-citationThe evolution of mutation rates: separating causes from consequences
Sniegowski, P. D., Gerrish, P. J., Johnson, T., & Shaver, A. (2000) · BioEssays · doi:10.1002/1521-1878(200012)22:12<1057::aid-bies3>3.0.co;2-w · Cited by 497
Tumor hypoxia and malignant progression
Vaupel, P., Mayer, A., & Höckel, M. (2004) · Methods in Enzymology · doi:10.1016/s0076-6879(04)81023-1 · Cited by 496
APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity
Swanton, C., McGranahan, N., Starrett, G. J., & Harris, R. S. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0344 · Cited by 488
Dynamics of cancer progression
Michor, F., Iwasa, Y., & Nowak, M. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1295 · Cited by 483
Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells
Klein, C. A., Schmidt-Kittler, O., Schardt, J. A., Pantel, K., Speicher, M. R., & Riethmüller, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4494 · Cited by 450
Molecular pathological classification of colorectal cancer
Müller, M. F., Ibrahim, A. E. K., & Arends, M. J. (2016) · Virchows Archiv · doi:10.1007/s00428-016-1956-3 · Cited by 432
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
Gerlinger, M., & Swanton, C. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605912 · Cited by 421
Mouradov, D., Sloggett, C., Jorissen, R. N., Love, C. G., Li, S., Burgess, A. W., Arango, D., Strausberg, R. L., Buchanan, D., Wormald, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0013 · Cited by 375
Self-citationBiological responses to electromagnetic fields 1
Lacy‐hulbert, A., Metcalfe, J. C., & Hesketh, R. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.6.395 · Cited by 328
Myung, K., Datta, A., & Kolodner, R. D. (2001) · Cell · doi:10.1016/s0092-8674(01)00227-6 · Cited by 327
Genomic instability — the engine of tumorigenesis?
Sieber, O. M., Heinimann, K., & Tomlinson, I. P. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1170 · Cited by 324
Self-citationEvolution in Health and Disease
(2007) · doi:10.1093/acprof:oso/9780199207466.001.0001 · Cited by 320
Impact of deleterious passenger mutations on cancer progression
McFarland, C. D., Korolev, K. S., Kryukov, G. V., Sunyaev, S. R., & Mirny, L. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213968110 · Cited by 317
Evidence for Selective Advantage of Pathogenic FGFR2 Mutations in the Male Germ Line
Goriely, A., McVean, G. A. T., Röjmyr, M., Ingemarsson, B., & Wilkie, A. O. M. (2003) · Science · doi:10.1126/science.1085710 · Cited by 310
Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog
Tomlinson, I., & Bodmer, W. (1999) · Nature Medicine · doi:10.1038/4687 · Cited by 296
Self-citationRubin, H. (2001) · Carcinogenesis · doi:10.1093/carcin/22.12.1903 · Cited by 261
Genetic pathways in colorectal and other cancers
Ilyas, M., Straub, J., Tomlinson, I. P. M., & Bodmer, W. F. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00431-6 · Cited by 257
Self-citationAPC and Its Modifiers in Colon Cancer
Kwong, L. N., & Dove, W. F. (2009) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-1145-2_8 · Cited by 254
Somatic mutations and aging: a re-evaluation
Vijg, J. (2000) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00202-x · Cited by 243
Goetzman, E. S., & Prochownik, E. V. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00129 · Cited by 199
Diverse mutational landscapes in human lymphocytes
Machado, H. E., Mitchell, E., Øbro, N. F., Kübler, K., Davies, M., Leongamornlert, D., Cull, A., Maura, F., Sanders, M. A., Cagan, A. T. J., et al. (2022) · Nature · doi:10.1038/s41586-022-05072-7 · Cited by 116
Metadata
- Authors
- Tomlinson, I. P. M., Novelli, M. R., & Bodmer, W. F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-12-10
- Volume
- 93
- Issue
- 25
- Pages
- 14800-14803
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2065423665
- Cited by
- 458
- References
- 28
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.